Retraction notices

High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD1)-Mediated Function of T Cells

Type

Retraction

Notice date

9/7/2021 0:00

Journal

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Publisher

Cognizant Communication Corporation

Notice DOI

10.3727/096504018x16233193839045

Original paper DOI

10.3727/096504018x15456687424096

Reasons

• Error in Cell Lines/Tissues
• Error in Materials
• Error in Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics